MENU

Fox Chase Cancer Center Welcomes Dr. Zachary Frosch

July 20, 2021

Zachary Frosch, MD, MSHP joins the Department of Hematology/OncologyZachary Frosch, MD, MSHP joins the Department of Hematology/Oncology

PHILADELPHIA (July 20, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Zachary Frosch, MD, MSHP, who will join the Department of Hematology/Oncology as an assistant professor.

Frosch will join the staff following completion of his fellowship in hematology/oncology and a Master of Science in Health Policy Research degree at the University of Pennsylvania. During this time, he also served as an Innovation Fellow at the Penn Center for Cancer Care Innovation and an associate fellow at the Leonard Davis Institute of Health Economics.    

Frosch is a graduate of the Perelman School of Medicine at the University of Pennsylvania and completed his residency in internal medicine at Brigham and Women’s Hospital in Boston, which is a teaching affiliate of Harvard Medical School.

During his residency, he also served as a chief medical resident for VA Boston, West Roxbury Campus, and helped to design and implement the residency’s Scholars in Medical Education Pathway.

Following his residency, he served from 2017 to 2018 as associate director of the Scholars in Medical Education Pathway, as an instructor in medicine at Harvard Medical School, and as a physician in the Dana-Farber Cancer Institute’s Division of Oncology Hospital Medicine. He was also named a scholar in the Harvard Macy Program for Educators in the Health Professions at Harvard Medical School.

He has received numerous awards, including a 2021 American Society of Clinical Oncology/Conquer Cancer Foundation Young Investigator Award and the Martin P. Solomon Primary Care Scholarship Award from Brigham and Women’s Hospital. He is also a member of the Alpha Omega Alpha and Phi Beta Kappa honor societies.

Frosch will begin work at Fox Chase on August 1, 2021.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase